The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 08, 2017
Filed:
Nov. 28, 2012
Applicant:
Daewoong Pharmaceutical Co., Ltd., Gyeonggi-do, KR;
Inventors:
Jong-Wook Lee, Gyeonggi-do, KR;
Sang-Ho Lee, Gyeonggi-do, KR;
Taek-Joo Lim, Seoul, KR;
Eun-Ji Koh, Gyeonggi-do, KR;
Assignee:
DAEWOONG PHARMACEUTICAL CO., LTD., Gyeonggi-do, KR;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/421 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); C07D 263/22 (2006.01); A61K 31/216 (2006.01); A61K 31/4422 (2006.01); A61K 45/06 (2006.01); A61K 31/41 (2006.01);
U.S. Cl.
CPC ...
A61K 31/421 (2013.01); A61K 31/216 (2013.01); A61K 31/41 (2013.01); A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/4422 (2013.01); A61K 45/06 (2013.01); C07D 263/22 (2013.01);
Abstract
Provided is a pharmaceutical composition for preventing or treating hyperlipidemia comprising (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt; and an angiotensin II receptor blocker as active ingredients.